UNSPSC 51161716: Doxapram

This classification denotes a cns stimulant with the molecular formula C24H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94F3830Q73, chemically known as 2-pyrrolidinone, 1-ethyl-4- (2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride but generally known as doxapram, which bears US NIH Compound Identifier 3156. European Medicines Agency schedules Doxapram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06382MIG.

UNSPSC 51161716 Doxapram is a Commodity code that covers respiratory stimulant pharmaceuticals and related drug products, though state and local procurement activity under this code does not align with the code's nominal scope — recent opportunities show instead that issuing bodies are purchasing naloxone (an opioid antagonist used in overdose reversal) and pharmacy services, which fall outside doxapram's therapeutic category. The source shows minimal relevant recent activity under the stated code; the opportunities posted are tagged to it but represent distinct drug procurement and clinical pharmacy management rather than doxapram supply. Issuing bodies purchasing under this code span county health departments and county government employee health programs, reflecting the diversity of public-sector healthcare procurement across different jurisdictions and use cases.

Geographic activity centers on Florida and Georgia based on recent postings. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. Hall County, Georgia posted an RFQ/P (#47-010) on May 4, 2026, seeking an on-site pharmacy services provider for the Hall County Government Family Health Center Clinic in Gainesville to serve approximately 3,005 eligible individuals, with sealed proposals due June 4, 2026, at 2:00 p.m. Eastern Time and a one-year initial contract term beginning January 1, 2027. Neither opportunity specifies set-aside designations for disadvantaged enterprises. The code shows limited and thematically misaligned recent state and local procurement activity; firms evaluating pursuit should verify the code's relevance to their product or service offering before investing in opportunity tracking under this category.